KSA
PFE icon

Ken Stern & Associates’s Pfizer PFE Stock Holding History

Ken Stern & Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$833K Buy
19,930
+3
+0% +$115 0.36% 33
2018
Q2 		$686K Buy
19,927
+1,334
+7% +$45.6K 0.32% 33
2018
Q1 		$626K Buy
18,593
+772
+4% +$26.5K 0.28% 38
2017
Q4 		$612K Sell
17,821
-2
-0% -$68 0.27% 43
2017
Q3 		$600K Buy
17,823
+603
+4% +$19.4K 0.27% 42
2017
Q2 		$550K Buy
17,220
+838
+5% +$26.4K 0.25% 43
2017
Q1 		$527K Buy
16,382
+1,138
+7% +$35.9K 0.25% 46
2016
Q4 		$470K Buy
15,244
+5,136
+51% +$157K 0.24% 53
2016
Q3 		$325K Buy
10,108
+1,634
+19% +$54.6K 0.22% 63
2016
Q2 		$283K Buy
+8,474
New +$270K 0.22% 67

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ken Stern & Associates's PFE Position: Q3 2018 in Review

Ken Stern & Associates increased its Pfizer (PFE) stake by 0.02% in Q3 2018, buying an estimated $115 and bringing the position to 19,930 shares worth $833K. The position accounts for 0.36% of the portfolio, ranked #33.

Ken Stern & Associates first reported a position in PFE in Q2 2016 and has held it in 10 quarters since. 2,256 funds tracked by Wall St. Rank hold PFE as of Q3 2018.

  • Ken Stern & Associates held 19,930 shares of Pfizer worth $833K as of Q3 2018.
  • Ken Stern & Associates bought 3 Pfizer shares in Q3 2018, an estimated $115.
  • Pfizer made up 0.36% of Ken Stern & Associates's portfolio in Q3 2018, its #33 holding.
  • Ken Stern & Associates first reported a position in Pfizer in Q2 2016 and has held it in 10 quarters since.
  • 2,256 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.

Based on Ken Stern & Associates's 13F filing for Q3 2018, filed 13 Nov 2018.